Susan Altschuller Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

Susan Altschuller is Chief Financial Officer of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 16,913 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Susan ALTSCHULLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2024	SELL Sale (or disposition) back to the issuer	-	16,913 Reduced 100.0%	0 Common Stock
Dec 20 2023	SELL Open market or private sale	$571,927 $41.42 p/Share	13,808 Reduced 44.95%	16,913 Common Stock
Dec 19 2023	BUY Exercise of conversion of derivative security	-	30,721 Added 50.0%	30,721 Common Stock

Also insider at

IMGN

ImmunoGen, Inc. Healthcare

SVP AND CFO

MURA

Mural Oncology plc